NKF K/DOQI GUIDELINES
Executive Summaries | Anemia | Hemodialysis | Peritoneal Dialysis |
Vascular Access | Nutrition | CKD 2002 | Dyslipidemias | Bone Metabolism | Hypertension and Antihypertensive Agents | History of K/DOQI
| |
NKF K/DOQI GUIDELINES Executive Summaries | Anemia | Hemodialysis | Peritoneal Dialysis | |
WORK GROUP MEMBERSHIP
Chair:
Andrew S. Levey, MD
Tufts-New England Medical Center
Boston, MA
Vice-Chair:
Michael V. Rocco, MD, MS
Wake Forest University School of Medicine
Winston Salem, NC
Sharon Anderson, MD Sharon P. Andreoli, MD George R. Bailie, PharmD, PhD George L. Bakris, MD Mary Beth Callahan, ACSW, LMSW, ACP Jane H. Greene, RD, CSR Cynda Ann Johnson, MD, MBA James P. Lash, MD |
Peter A. McCullough, MD, MPH Edgar R. Miller III, MD, PhD Joseph V. Nally, MD John D. Pirsch, MD University of Texas Houston, TX Mary Ann Sevick, RN, ScD Domenic Sica, MD Donald E. Wesson, MD |
Liaison Members:
| Lawrence Agodoa, MD National Institutes of Health NIDDK Silver Springs, MD |
Jeffrey A. Cutler, MD, MPH National Institutes of Health NHLBI Bethesda, MD |
| Kline Bolton, MD (RPA) University of Virginia Hospital Charlottesville, VA |
Tom Hostetter, MD National Institutes of Health NIDDK Bethesda, MD |
Evidence Review Team:
Joseph Lau, MD, Director
Tufts-New England Medical Center
Boston, MA
Katrin Uhlig, MD, Assistant Director
Tufts-New England Medical Center
Boston, MA
| Priscilla Chew, MPH Annamaria Kausz, MD, MS Bruce Kupelnick, BA Gowri Raman, MD Mark Sarnak, MD Chenchen Wang, MD, MSc Tufts-New England Medical Center Boston, MA |
Brad C. Astor, PhD, MPH Johns Hopkins University Baltimore, MD |
© 2004 National Kidney Foundation, Inc |